XpresSpa Group Begins Construction of New XpresCheck™ COVID-19 Testing Facility at Logan International Airport in Boston
Expected to Commence Operations by November
First Presence Outside the
XpresCheck is currently building a modular constructed testing facility within the International Arrival area, pre security Terminal E, that is expected to host seven separate testing rooms with an anticipated capacity to administer over 400 tests per day. COVID-19 testing options will include a rapid molecular COVID-19 test, the Polymerase Chain Reaction (PCR) Test, and the Blood Antibody Test. All three tests are similarly offered at the XpresCheck locations in
This press release may contain "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. These include statements preceded by, followed by or that otherwise include the words "believes," "expects," "anticipates," "estimates," "projects," "intends," "should," "seeks," "future," "continue," or the negative of such terms, or other comparable terminology. In particular, these statements include, without limitation, statements about our expectations relating to our new XpresCheck™ concept and our ability to open our XpresCheck™ location at
Source: XpresSpa Group, Inc.